Therefore, our case expands the phenotypic and geographic context for OPA1-associated optic neuropathy and motivates segregation testing, broader genetic screening, and functional studies to clarify pathogenicity and improve diagnostic accuracy in underrepresented populations such as those in the Caribbean. The gene discussed is OPA1; the disease is optic nerve disorder.